Risperidone Release from Solid Lipid Nanoparticles (SLN): Validated HPLC Method and Modelling Kinetic Profile

E-ISSN： 1875-676x|8|4|307-316

ISSN： 1573-4129

Source： Current Pharmaceutical Analysis, Vol.8, Iss.4, 2012-11, pp. : 307-316

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Solid lipid nanoparticles (SLN) for controlled drug delivery - Drug release and release mechanism

By zur Muhlen A. Schwarz C. Mehnert W.

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 45, Iss. 2, 1998-03 ,pp. : 149-155

Elsevier

Access to resources Recommend Favorite

Spray-drying of solid lipid nanoparticles (SLN TM )

By Freitas C. Muller R.H.

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 46, Iss. 2, 1998-09 ,pp. : 145-151

Elsevier

Access to resources Recommend Favorite

Tamoxifen Citrate Loaded Solid Lipid Nanoparticles (SLN™): Preparation, Characterization, In Vitro Drug Release, and Pharmacokinetic Evaluation

By Harivardhan Reddy L. Vivek K. Bakshi Nishant Murthy R.S.R.

Pharmaceutical Development and Technology, Vol. 11, Iss. 2, 2006-07 ,pp. : 167-177

Informa Healthcare

Access to resources Recommend Favorite

Characterization Methods for Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC)

Current Pharmaceutical Design, Vol. 23, Iss. 43, 2018-02 ,pp. : 6630-6642

Bentham Science Publishers

Access to resources Recommend Favorite

Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art

By Muller R.H. Mader K. Gohla S.

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 50, Iss. 1, 2000-07 ,pp. : 161-177

Elsevier

Access to resources Recommend Favorite